Effect of phentermine on weight reduction in a pediatric weight management clinic

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Phentermine is the most widely prescribed obesity medication in adults, yet studies of its use in the pediatric population are limited. We conducted a retrospective chart review of adolescents with obesity treated in a pediatric weight management clinic to examine the weight loss effectiveness of phentermine added to standard of care (SOC) lifestyle modification therapy versus SOC alone. All patients receiving phentermine plus SOC (n=25) were matched with a comparison group receiving only SOC (n=274). Differences at 1, 3 and 6 months were evaluated using generalized estimated equations adjusting for age, sex and baseline body mass index (BMI) and robust variance standard error estimates for confidence intervals and P-values. Phentermine use was associated with a greater percent change in BMI at 1 month (-1.6%; 95% confidence interval (CI): -2.6, -0.6%; P=0.001), 3 months (-2.9%; 95% CI: -4.5, -1.4%; P<0.001) and 6 months (-4.1%; 95% CI: -7.1, -1.0%; P=0.009) compared with SOC alone, with no differences in systolic or diastolic blood pressure between groups. Heart rate was higher at all time-points in the phentermine plus SOC compared with SOC-only group. These data suggest that short-term use of phentermine added to SOC may enhance weight loss in adolescents with obesity in the clinical setting.

Original languageEnglish (US)
Pages (from-to)90-93
Number of pages4
JournalInternational Journal of Obesity
Volume41
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Phentermine
Standard of Care
Weight Loss
Pediatrics
Weights and Measures
Confidence Intervals
Pediatric Obesity
Body Mass Index
Blood Pressure
Life Style
Obesity
Heart Rate

Cite this

@article{3c0e1069201b4539958e104b55db0056,
title = "Effect of phentermine on weight reduction in a pediatric weight management clinic",
abstract = "Phentermine is the most widely prescribed obesity medication in adults, yet studies of its use in the pediatric population are limited. We conducted a retrospective chart review of adolescents with obesity treated in a pediatric weight management clinic to examine the weight loss effectiveness of phentermine added to standard of care (SOC) lifestyle modification therapy versus SOC alone. All patients receiving phentermine plus SOC (n=25) were matched with a comparison group receiving only SOC (n=274). Differences at 1, 3 and 6 months were evaluated using generalized estimated equations adjusting for age, sex and baseline body mass index (BMI) and robust variance standard error estimates for confidence intervals and P-values. Phentermine use was associated with a greater percent change in BMI at 1 month (-1.6{\%}; 95{\%} confidence interval (CI): -2.6, -0.6{\%}; P=0.001), 3 months (-2.9{\%}; 95{\%} CI: -4.5, -1.4{\%}; P<0.001) and 6 months (-4.1{\%}; 95{\%} CI: -7.1, -1.0{\%}; P=0.009) compared with SOC alone, with no differences in systolic or diastolic blood pressure between groups. Heart rate was higher at all time-points in the phentermine plus SOC compared with SOC-only group. These data suggest that short-term use of phentermine added to SOC may enhance weight loss in adolescents with obesity in the clinical setting.",
author = "Ryder, {Justin R} and A. Kaizer and Kyle Rudser and Gross, {Amy C} and Kelly, {Aaron S} and Fox, {Claudia K}",
year = "2017",
month = "1",
day = "1",
doi = "10.1038/ijo.2016.185",
language = "English (US)",
volume = "41",
pages = "90--93",
journal = "International Journal of Obesity",
issn = "0307-0565",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Effect of phentermine on weight reduction in a pediatric weight management clinic

AU - Ryder, Justin R

AU - Kaizer, A.

AU - Rudser, Kyle

AU - Gross, Amy C

AU - Kelly, Aaron S

AU - Fox, Claudia K

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Phentermine is the most widely prescribed obesity medication in adults, yet studies of its use in the pediatric population are limited. We conducted a retrospective chart review of adolescents with obesity treated in a pediatric weight management clinic to examine the weight loss effectiveness of phentermine added to standard of care (SOC) lifestyle modification therapy versus SOC alone. All patients receiving phentermine plus SOC (n=25) were matched with a comparison group receiving only SOC (n=274). Differences at 1, 3 and 6 months were evaluated using generalized estimated equations adjusting for age, sex and baseline body mass index (BMI) and robust variance standard error estimates for confidence intervals and P-values. Phentermine use was associated with a greater percent change in BMI at 1 month (-1.6%; 95% confidence interval (CI): -2.6, -0.6%; P=0.001), 3 months (-2.9%; 95% CI: -4.5, -1.4%; P<0.001) and 6 months (-4.1%; 95% CI: -7.1, -1.0%; P=0.009) compared with SOC alone, with no differences in systolic or diastolic blood pressure between groups. Heart rate was higher at all time-points in the phentermine plus SOC compared with SOC-only group. These data suggest that short-term use of phentermine added to SOC may enhance weight loss in adolescents with obesity in the clinical setting.

AB - Phentermine is the most widely prescribed obesity medication in adults, yet studies of its use in the pediatric population are limited. We conducted a retrospective chart review of adolescents with obesity treated in a pediatric weight management clinic to examine the weight loss effectiveness of phentermine added to standard of care (SOC) lifestyle modification therapy versus SOC alone. All patients receiving phentermine plus SOC (n=25) were matched with a comparison group receiving only SOC (n=274). Differences at 1, 3 and 6 months were evaluated using generalized estimated equations adjusting for age, sex and baseline body mass index (BMI) and robust variance standard error estimates for confidence intervals and P-values. Phentermine use was associated with a greater percent change in BMI at 1 month (-1.6%; 95% confidence interval (CI): -2.6, -0.6%; P=0.001), 3 months (-2.9%; 95% CI: -4.5, -1.4%; P<0.001) and 6 months (-4.1%; 95% CI: -7.1, -1.0%; P=0.009) compared with SOC alone, with no differences in systolic or diastolic blood pressure between groups. Heart rate was higher at all time-points in the phentermine plus SOC compared with SOC-only group. These data suggest that short-term use of phentermine added to SOC may enhance weight loss in adolescents with obesity in the clinical setting.

UR - http://www.scopus.com/inward/record.url?scp=84996772758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996772758&partnerID=8YFLogxK

U2 - 10.1038/ijo.2016.185

DO - 10.1038/ijo.2016.185

M3 - Article

C2 - 27773937

AN - SCOPUS:84996772758

VL - 41

SP - 90

EP - 93

JO - International Journal of Obesity

JF - International Journal of Obesity

SN - 0307-0565

IS - 1

ER -